UPDATE 1-GSK stops Tykerb only arm of late-stage trial | Reuters
Links shared publicly online about this topic.
- 11total visits
UPDATE 1-GSK stops Tykerb only arm of late-stage trial | Reuters
* Trial looks at Tykerb versus Roche's Herceptin * Three other arms of late-stage study to continue * GSK shares weaken (Adds details, background) LONDON, Sept 9 (Reuters) - Patients in a late
View full resource at reuters.com
Tags: Breast Cancer Medication, Herceptin, GlaxoSmithKline
Most Recently Shared on September 9, 2011 at 12:40 pm By:
Tykerb + Herceptin ongoing RT @JohnCFierce: Tykerb-alone trial arm dropped; results unlikely to match Herceptin. http://t.co/SWWsQ5V
Also Shared By:
Advertisement
John Carroll
@JohnCFierce
Trial arm for Tykerb-alone dropped; patients likely to do worse than herceptin. http://t.co/wWlmgMw
1 year ago...